Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Kitas

Showing results (71-80 of 411) with videos related to

Pageof 42
Sort By:
BMC Musculoskeletal Disorders|September 10, 2002
Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndromeJ H Raphael, J L Southall, G J Treharne, et al.
Annals of Laboratory Medicine|February 28, 2019
The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic DiseasesArmen Yuri Gasparyan, Lilit Ayvazyan, Ulzhan Mukanova, et al.
British Journal of Health Psychology|July 21, 2007
Psychological well-being across 1 year with rheumatoid arthritis: coping resources as buffers of perceived stressGareth J Treharne, Antonia C Lyons, David A Booth, et al.
Clinical Rheumatology|September 8, 2022
Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responsesPankti Mehta, Armen Yuri Gasparyan, Olena Zimba, et al.
Rheumatology International|May 3, 2022
The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 eraGerasimos Evangelatos, Giorgos Bamias, George D Kitas, et al.
Bailliere'S Clinical Rheumatology|May 1, 1997
Disease assessment and management of the vasculitidesR A Luqmani, A R Exley, G D Kitas, et al.
Clinical Rheumatology|June 11, 2014
Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockadeKonstantinos Makrilakis, Kalliopi Fragiadaki, Jacqueline Smith, et al.
Inflammation & Allergy Drug Targets|May 28, 2014
Cardiac and muscular involvement in idiopathic inflammatory myopathies: noninvasive diagnostic assessment and the role of cardiovascular and skeletal magnetic resonance imagingSophie Mavrogeni, Petros P Sfikakis, Theodoros Dimitroulas, et al.
Seminars in Arthritis and Rheumatism|January 9, 2017
Biologic drugs as analgesics for the management of osteoarthritisTheodoros Dimitroulas, Tosin Lambe, Rainer Klocke, et al.
Journal of Health Psychology|April 29, 2005
Well-being in rheumatoid arthritis: the effects of disease duration and psychosocial factorsGareth J Treharne, George D Kitas, Antonia C Lyons, et al.
Pageof 42

Showing results (71-80 of 411) with videos related to

Sort By:
Pageof 42
BMC Musculoskeletal Disorders|September 10, 2002
Efficacy and adverse effects of intravenous lignocaine therapy in fibromyalgia syndromeJ H Raphael, J L Southall, G J Treharne, et al.
Annals of Laboratory Medicine|February 28, 2019
The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic DiseasesArmen Yuri Gasparyan, Lilit Ayvazyan, Ulzhan Mukanova, et al.
British Journal of Health Psychology|July 21, 2007
Psychological well-being across 1 year with rheumatoid arthritis: coping resources as buffers of perceived stressGareth J Treharne, Antonia C Lyons, David A Booth, et al.
Clinical Rheumatology|September 8, 2022
Interplay of diabetes mellitus and rheumatic diseases amidst the COVID-19 pandemic: influence on the risk of infection, outcomes, and immune responsesPankti Mehta, Armen Yuri Gasparyan, Olena Zimba, et al.
Rheumatology International|May 3, 2022
The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 eraGerasimos Evangelatos, Giorgos Bamias, George D Kitas, et al.
Bailliere'S Clinical Rheumatology|May 1, 1997
Disease assessment and management of the vasculitidesR A Luqmani, A R Exley, G D Kitas, et al.
Clinical Rheumatology|June 11, 2014
Interrelated reduction of chemerin and plasminogen activator inhibitor-1 serum levels in rheumatoid arthritis after interleukin-6 receptor blockadeKonstantinos Makrilakis, Kalliopi Fragiadaki, Jacqueline Smith, et al.
Inflammation & Allergy Drug Targets|May 28, 2014
Cardiac and muscular involvement in idiopathic inflammatory myopathies: noninvasive diagnostic assessment and the role of cardiovascular and skeletal magnetic resonance imagingSophie Mavrogeni, Petros P Sfikakis, Theodoros Dimitroulas, et al.
Seminars in Arthritis and Rheumatism|January 9, 2017
Biologic drugs as analgesics for the management of osteoarthritisTheodoros Dimitroulas, Tosin Lambe, Rainer Klocke, et al.
Journal of Health Psychology|April 29, 2005
Well-being in rheumatoid arthritis: the effects of disease duration and psychosocial factorsGareth J Treharne, George D Kitas, Antonia C Lyons, et al.
Pageof 42